CME 8 Session – EANM’13

The Diabetic Patient

Educational objectives:
  1. To identify clinical unmet needs in patients with diabetes
  2. To define nuclear medicine procedures that can be used to diagnose and monitor infectious and inflammatory processes in patients with diabetes
  3. To address specific clinical entities such as diabetic nephropathy and atherosclerosis and define the role of nuclear medicine in monitoring disease progress or response to therapeutic procedures
This continuing education session is directed primarily towards nuclear medicine practitioners and clinicians involved in the care of patients with diabetes. Infectious and inflammatory processes occur with a high incidence in diabetic patients and pose significant clinical challenges both for diagnosis and management. Diabetic nephropathy, atherosclerotic cardiovascular disease, impaired myocardial sympathetic innervation and orthopaedic infection, such as osteomyelitis in the “diabetic foot” are severe complications occurring as consequences of prolonged or poorly controlled diabetes. These, as well as additional clinical entities, can be tracked by the use of nuclear medicine techniques. In addition to the use of single photon emitting tracers, imaging with positron emitting radioisotopes has gained wide applications in infection supplemented by the successful implementation of hybrid SPECT/CT and PET/CT. Caution in the use of FDG in patients with diabetes has been previously advocated and was considered to limit its clinical value in this subgroup of patients.
This CME will present an overview of clinical questions in patients with diabetes and diagnostic keys that can be provided by a variety of nuclear medicine procedures.

Key Words:
Diabetes, Infection, Kidney, Atherosclerosis, PET/CT, SPECT

Extended Abstract Book for download (5 MB)

User action required
If you have the permission to view this publication, please log in.